What Is My Home Health Care Business Worth in 2026?

A home health care business is worth 3.5x–4.5x SDE for smaller owner-operated agencies, or 6.0x–8.0x EBITDA for Medicare-certified operations with $1M+ in EBITDA. BrightSpring Health Services — which just completed a $239M acquisition of former Amedisys and LHC Group locations — and Pennant Group are the most active strategic acquirers in 2026. PE-backed platforms are consolidating aggressively, particularly chasing agencies with strong Medicare certification, diversified payor mix, and low caregiver turnover.

This guide is for owners of home health care agencies — whether you're Medicare-certified, private-pay, or a hybrid model — who want to understand what their business is actually worth in today's market and who's likely to buy it.

How Are Home Health Care Businesses Valued?

Smaller agencies — those below $500K in SDE — are almost always valued on an SDE multiple. The buyer is typically an individual operator or a small regional platform, and they're underwriting their own replacement of you as the owner. That puts multiples in the 3.5x–4.0x range for clean, well-documented agencies. If you have high caregiver turnover, heavy owner dependency, or concentration risk with one referral source, that multiple compresses.

For agencies above $1M EBITDA — particularly those with Medicare certification, state licensure in good standing, and a diversified payor mix — the valuation method shifts to EBITDA. Institutional buyers use this metric because they can layer management on top and the business continues running. At $1.5M EBITDA with 12% margins, strong referrals, and professional staffing, you're looking at a 6x–7x multiple, putting value in the $9M–$10.5M range. The best-positioned agencies are hitting 8x when there's real growth trajectory and a strong clinical compliance record.

One thing I emphasize with every home health seller: the 36-month Medicare rule matters. Buyers want clean ownership history and no pending cost report issues. Agencies that have their financials in order — two years of reconciled cost reports, no RAC audit exposure — command stronger multiples and shorter due diligence timelines.

What Are Current Multiples for Home Health Care Agencies?

In 2026, the typical SDE multiple for a home health care agency runs 3.5x–4.5x for owner-operated businesses under $3M in revenue. Medicare-certified agencies with $1M+ EBITDA are achieving 6.0x–8.0x EBITDA from institutional buyers. The spread between those two tiers has widened over the past 18 months as large strategics — BrightSpring, Pennant Group, and PE-backed rollup platforms — compete specifically for scale-ready operations.

What separates the 3.5x agency from the 4.5x agency? Three things: caregiver retention rate, referral source diversification, and owner independence. Agencies with turnover 20% or more below the national average and three-plus hospital or ACO referral relationships regularly achieve the top of the SDE range. Agencies where the owner is the primary intake person and clinical supervisor are valued at the bottom of the range — sometimes below 3x if the buyer perceives genuine continuity risk.

Who Is Buying Home Health Care Businesses in 2026?

BrightSpring Health Services is the most active large-platform buyer, having acquired 107 home health and hospice locations in a $239M deal with UnitedHealth Group in late 2025. Pennant Group paid $102.5M as part of the same divestiture. These two players are now actively looking for bolt-on acquisitions to fill geographic gaps in their networks.

Below the national platforms, regional PE-backed rollups are highly active. Private equity now owns 18%+ of the nation's home care market by location count, and the consolidation trend shows no sign of slowing. PE firms are specifically targeting agencies with $2M–$10M in revenue, clean regulatory records, and strong referral pipelines. Individual strategic buyers — operators who already run one or two locations — are also competitive for smaller agencies in the $500K–$2M revenue range, often paying strong multiples because they understand the operational model and can integrate quickly.

For more on the broader home care M&A market, see the Home Health Care industry hub. If you're also considering how your business compares to related healthcare services, the Hospice Care valuation guide covers adjacent buyer dynamics worth understanding.

What Makes a Home Health Care Business Worth More?

The biggest multiple expanders are Medicare certification, payor mix quality, and operational independence. A Medicare-certified agency commands a premium over private-pay only — institutional buyers need the certification to bill and are willing to pay for it. Commercial and Medicare payor mix matters more than raw revenue: an agency with 70% Medicare and 20% commercial at $2M revenue will outsell a $3M agency where 60% is Medicaid on a multiple basis.

Operational independence is the second driver I see most consistently. When I work with home health sellers who have a clinical director, intake coordinator, and scheduling team in place — and the owner is purely in a management and strategy role — the buyer pool expands dramatically and multiples follow. Agencies where the owner is also the lead RN and primary referral relationship holder struggle to break 3.5x SDE regardless of revenue.

Technology adoption also matters now in ways it didn't five years ago. Electronic visit verification (EVV) compliance, a modern EMR system, and clean billing records reduce buyer due diligence time and signal operational sophistication. Buyers discount for agencies running on paper-based systems or using outdated billing software.

What Hurts Home Health Care Valuations?

Regulatory exposure is the biggest value killer in home health. Open cost reports, pending CMS audits, billing compliance issues, or a history of OASIS corrections create immediate uncertainty for buyers and often result in deal structure shifting away from cash at close toward an earnout. I've seen deals fall apart entirely because of undisclosed compliance issues discovered during due diligence.

Payor concentration is the next major risk factor. If 60% or more of your revenue flows through a single referral source — one hospital system, one physician group, one ACO — buyers will discount heavily. Referral concentration means the revenue walks if that relationship doesn't transfer cleanly. Sellers who can demonstrate three-plus independent referral pipelines are in fundamentally stronger positions.

High caregiver turnover compounds every other problem. It increases costs, signals culture issues, and raises patient safety concerns for buyers doing operational diligence. Agencies with turnover rates above 60% annually will struggle to achieve even the low end of current multiples.

How Long Does It Take to Sell a Home Health Care Business?

A typical home health agency sale takes 9–12 months from first conversation to close on a clean deal. That includes 60–90 days to prepare financials and marketing materials, 60–90 days in the market to identify qualified buyers, 60–90 days of due diligence, and 30–60 days for regulatory approval and closing. Medicare certification transfers require CMS notification and have their own timeline, which is why experienced advisors build that into the process from day one.

The best outcomes come from sellers who prepare 12–24 months in advance — stabilizing census, diversifying referral sources, cleaning up compliance records, and strengthening management depth before a buyer ever sees the financials. That preparation is what separates a 4.0x close from a 3.5x close.

John's Take: "The home health care market in 2026 is the most active I've seen in a decade. BrightSpring's $239M deal with UnitedHealth signals that the national platforms are hungry for scale — and that appetite flows downstream to regional buyers looking for bolt-on opportunities. I had a seller last year who ran a Medicare-certified agency with about $1.2M EBITDA, solid referral relationships, and a management team that didn't need her on daily calls. We had three serious offers within 45 days of going to market. She closed at 7.0x EBITDA. The agencies that don't sell well are the ones where the owner IS the business — every referral call goes through them, every clinical decision runs through them. Fix that before you sell. It's worth 50–100 basis points of multiple at close."